/
Stock
/
/

TRANSMEDICS GROUP

TMDX Insider Trades:
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-09
2025-06-10
RANGANATH ANIL
See remarks
S - Sale
Common Stock
-686
$140.00
-96,040
1
$4.84B
2025-05-27
2025-05-29
BASILE EDWARD
S - Sale
Common Stock
-5,000
$126.00
-630K
1
$4.84B
2025-05-27
2025-05-29
BASILE EDWARD
M - Exercise
Stock Option (Right to Buy)
-5,000
1
$4.84B
2025-05-27
2025-05-29
BASILE EDWARD
M - Exercise
Common Stock
5,000
$1.00
5,000
1
$4.84B
2025-05-23
2025-05-23
WEILL DAVID
S - Sale
Common Stock
-732
$124.00
-90,768
1
$4.84B
2025-05-22
2025-05-23
LOVELL STEPHANIE
A - Grant
Common Stock
2,134
$0.00
1
$4.84B
2025-05-22
2025-05-23
GUNDERSON THOMAS JAMES
A - Grant
Common Stock
2,134
$0.00
1
$4.84B
2025-05-22
2025-05-23
RAINES MERILEE
A - Grant
Common Stock
2,134
$0.00
1
$4.84B
2025-05-22
2025-05-23
TOBIN JAMES
A - Grant
Common Stock
2,134
$0.00
1
$4.84B
2025-05-22
2025-05-23
WEILL DAVID
A - Grant
Common Stock
2,134
$0.00
1
$4.84B
2025-05-22
2025-05-23
BASILE EDWARD
A - Grant
Common Stock
2,134
$0.00
1
$4.84B
2025-05-22
2025-05-23
KANIA EDWIN JR
A - Grant
Common Stock
2,134
$0.00
1
$4.84B
2025-05-09
2025-05-13
BASILE EDWARD
S - Sale
Common Stock
-6,000
$116.00
-696K
1
$4.84B
2025-05-09
2025-05-13
BASILE EDWARD
M - Exercise
Common Stock
6,000
$1.00
6,000
1
$4.84B
2025-05-09
2025-05-13
BASILE EDWARD
M - Exercise
Stock Option (Right to Buy)
-6,000
1
$4.84B
2025-03-03
2025-03-05
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-2,407
$76.00
-183K
1
$4.84B
2025-03-04
2025-03-04
GORDON STEPHEN
Chief Financial Officer
S - Sale
-5,942
$66.00
-392K
1
$4.84B
2025-02-25
2025-02-26
HASSANEIN WALEED
President & CEO
A - Grant
Stock Option (Right to Buy)
90,185
$0.00
1
$4.84B
2025-02-25
2025-02-26
HASSANEIN WALEED
President & CEO
A - Grant
Common Stock
59,781
$0.00
1
$4.84B
2025-02-24
2025-02-26
HERNANDEZ GERARDO
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
5,299
$0.00
1
$4.84B
2025-02-24
2025-02-26
CORCORAN NICHOLAS
SVP of Supply Chain and Operat...
A - Grant
Stock Option (Right to Buy)
19,079
$0.00
1
$4.84B
2025-02-24
2025-02-26
CORCORAN NICHOLAS
SVP of Supply Chain and Operat...
A - Grant
Common Stock
12,676
$0.00
1
$4.84B
2025-02-24
2025-02-26
HERNANDEZ GERARDO
Chief Financial Officer
A - Grant
Common Stock
3,521
$0.00
1
$4.84B
2025-02-24
2025-02-26
KHAYAL TAMER
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
26,499
$0.00
1
$4.84B
2025-02-24
2025-02-26
KHAYAL TAMER
Chief Commercial Officer
A - Grant
Common Stock
17,606
$0.00
1
$4.84B
2025-02-24
2025-02-26
RANGANATH ANIL
See remarks
A - Grant
Stock Option (Right to Buy)
8,479
$0.00
1
$4.84B
2025-02-24
2025-02-26
RANGANATH ANIL
See remarks
A - Grant
Common Stock
5,634
$0.00
1
$4.84B
2025-01-07
2025-01-10
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-1,083
$0.00
1
$4.84B
2025-01-07
2025-01-10
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
1,083
$13.00
14,079
1
$4.84B
2025-01-07
2025-01-10
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-1,083
$80.00
-86,640
1
$4.84B
2024-12-09
2024-12-11
HERNANDEZ GERARDO
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
18,922
$0.00
1
$4.84B
2024-12-09
2024-12-11
HERNANDEZ GERARDO
Chief Financial Officer
A - Grant
Common Stock
12,463
$0.00
1
$4.84B
2024-12-02
2024-12-04
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-1,084
$0.00
1
$4.84B
2024-12-02
2024-12-04
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
1,084
$13.00
14,092
1
$4.84B
2024-12-02
2024-12-04
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-1,084
$86.00
-93,224
1
$4.84B
2024-11-11
2024-11-13
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-1,458
$0.00
1
$4.84B
2024-11-11
2024-11-13
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
1,458
$38.00
55,404
1
$4.84B
2024-11-11
2024-11-13
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-1,458
$90.00
-131K
1
$4.84B
2024-11-05
2024-11-07
BASILE EDWARD
M - Exercise
Common Stock
6,750
$28.00
189K
1
$4.84B
2024-11-05
2024-11-07
BASILE EDWARD
M - Exercise
Stock Option (Right to Buy)
-6,750
$0.00
1
$4.84B
2024-11-05
2024-11-07
BASILE EDWARD
S - Sale
Common Stock
-6,750
$84.00
-567K
2
$4.84B
2024-11-01
2024-11-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
1,083
$13.00
14,079
1
$4.84B
2024-11-01
2024-11-05
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-1,083
$83.00
-89,889
1
$4.84B
2024-11-01
2024-11-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-1,083
$0.00
1
$4.84B
2024-11-01
2024-11-01
KHAYAL TAMER
Chief Commercial Officer
S - Sale
-7,625
$82.00
-625K
1
$4.84B
2024-10-15
2024-10-17
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-8,625
$0.00
1
$4.84B
2024-10-15
2024-10-17
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
8,625
$13.00
112K
1
$4.84B
2024-10-15
2024-10-17
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-8,625
$133.00
-1.15M
4
$4.84B
2024-10-01
2024-10-03
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-2,958
$148.00
-438K
9
$4.84B
2024-10-01
2024-10-03
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-2,958
$0.00
3
$4.84B
2024-10-01
2024-10-03
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
2,958
$33.00
97,614
3
$4.84B
2024-09-16
2024-09-17
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
8,625
$13.00
112K
1
$4.84B
2024-09-16
2024-09-17
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-8,625
$153.00
-1.32M
6
$4.84B
2024-09-16
2024-09-17
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-8,625
$0.00
1
$4.84B
2024-09-13
2024-09-17
TOBIN JAMES
G - Gift
Common Stock
18,000
$0.00
1
$4.84B
2024-09-13
2024-09-17
TOBIN JAMES
G - Gift
Common Stock
-18,000
$0.00
1
$4.84B
2024-09-03
2024-09-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
2,960
$33.00
97,680
3
$4.84B
2024-09-03
2024-09-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-2,960
$0.00
3
$4.84B
2024-09-03
2024-09-05
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-2,960
$160.00
-474K
8
$4.84B
2024-08-27
2024-08-29
CORCORAN NICHOLAS
SVP of Supply Chain and Operat...
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
2
$4.84B
2024-08-27
2024-08-29
CORCORAN NICHOLAS
SVP of Supply Chain and Operat...
M - Exercise
Common Stock
10,000
$70.00
700K
2
$4.84B
2024-08-27
2024-08-29
CORCORAN NICHOLAS
SVP of Supply Chain and Operat...
S - Sale
Common Stock
-10,000
$176.00
-1.76M
1
$4.84B
2024-08-22
2024-08-23
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
1
$4.84B
2024-08-22
2024-08-23
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
25,000
$16.00
400K
1
$4.84B
2024-08-22
2024-08-23
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-25,000
$175.00
-4.38M
1
$4.84B
2024-08-21
2024-08-23
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
20,000
$16.00
320K
1
$4.84B
2024-08-21
2024-08-23
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-20,000
$0.00
1
$4.84B
2024-08-21
2024-08-23
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-20,000
$171.00
-3.42M
1
$4.84B
2024-08-21
2024-08-21
HASSANEIN WALEED
President & CEO
S - Sale
-45,000
$173.00
-7.79M
1
$4.84B
2024-08-15
2024-08-19
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
8,625
$13.00
112K
1
$4.84B
2024-08-15
2024-08-19
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-8,625
$0.00
1
$4.84B
2024-08-15
2024-08-19
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-8,625
$170.00
-1.47M
7
$4.84B
2024-08-15
2024-08-15
HASSANEIN WALEED
President & CEO
S - Sale
-25,875
$163.00
-4.22M
1
$4.84B
2024-08-08
2024-08-09
TOBIN JAMES
S - Sale
Common Stock
-20,000
$159.00
-3.18M
2
$4.84B
2024-08-07
2024-08-09
RANGANATH ANIL
See remarks
M - Exercise
Stock Option (Right to Buy)
-4,289
$0.00
1
$4.84B
2024-08-07
2024-08-09
RANGANATH ANIL
See remarks
M - Exercise
Common Stock
4,289
$94.00
403K
1
$4.84B
2024-08-07
2024-08-09
RANGANATH ANIL
See remarks
S - Sale
Common Stock
-4,289
$152.00
-652K
1
$4.84B
2024-06-05
2024-08-09
RANGANATH ANIL
See remarks
S - Sale
Common Stock
-703
$135.00
-94,905
1
$4.84B
2024-08-06
2024-08-08
BASILE EDWARD
S - Sale
Common Stock
-6,750
$150.00
-1.01M
4
$4.84B
2024-08-06
2024-08-08
BASILE EDWARD
M - Exercise
Stock Option (Right to Buy)
-6,750
$0.00
1
$4.84B
2024-08-06
2024-08-08
BASILE EDWARD
M - Exercise
Common Stock
6,750
$28.00
189K
1
$4.84B
2024-08-01
2024-08-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
2,958
$33.00
97,614
3
$4.84B
2024-08-01
2024-08-05
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-2,958
$157.00
-464K
14
$4.84B
2024-08-01
2024-08-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-2,958
$0.00
3
$4.84B
2024-08-01
2024-08-01
KHAYAL TAMER
Chief Commercial Officer
S - Sale
-8,876
$164.00
-1.46M
1
$4.84B
2024-07-15
2024-07-17
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-8,625
$0.00
1
$4.84B
2024-07-15
2024-07-17
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
8,625
$13.00
112K
1
$4.84B
2024-07-15
2024-07-17
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-8,625
$145.00
-1.25M
5
$4.84B
2024-07-01
2024-07-03
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-2,958
$0.00
3
$4.84B
2024-07-01
2024-07-03
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
2,958
$33.00
97,614
3
$4.84B
2024-07-01
2024-07-03
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-2,958
$151.00
-447K
5
$4.84B
2024-06-14
2024-06-17
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-8,625
$0.00
1
$4.84B
2024-06-14
2024-06-17
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
8,625
$13.00
112K
1
$4.84B
2024-06-14
2024-06-17
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-8,625
$142.00
-1.22M
5
$4.84B
2024-06-05
2024-06-07
BASILE EDWARD
S - Sale
Common Stock
-1,193
$138.00
-165K
1
$4.84B
2024-06-03
2024-06-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
2,960
$33.00
97,680
3
$4.84B
2024-06-03
2024-06-05
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-2,060
$136.00
-280K
1
$4.84B
2024-06-03
2024-06-05
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-2,960
$133.00
-394K
7
$4.84B
2024-06-03
2024-06-05
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-2,060
$0.00
1
$4.84B
2024-06-03
2024-06-05
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
2,060
$38.00
78,280
1
$4.84B
2024-06-03
2024-06-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-2,960
$0.00
3
$4.84B
2024-05-29
2024-05-31
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-18,000
$0.00
5
$4.84B
2024-05-29
2024-05-31
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
18,000
$39.00
702K
5
$4.84B
2024-05-29
2024-05-31
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-20,000
$141.00
-2.82M
3
$4.84B
2024-05-29
2024-05-31
WEILL DAVID
S - Sale
Common Stock
-1,193
$142.00
-169K
1
$4.84B
2024-05-23
2024-05-28
BASILE EDWARD
A - Grant
Stock Option (Right to Buy)
1,154
$0.00
1
$4.84B
2024-05-23
2024-05-28
BASILE EDWARD
A - Grant
Common Stock
732
$0.00
1
$4.84B
2024-05-23
2024-05-28
GUNDERSON THOMAS JAMES
A - Grant
Stock Option (Right to Buy)
1,154
$0.00
1
$4.84B
2024-05-23
2024-05-28
GUNDERSON THOMAS JAMES
A - Grant
Common Stock
732
$0.00
1
$4.84B
2024-05-23
2024-05-28
KANIA EDWIN JR
A - Grant
Stock Option (Right to Buy)
1,154
$0.00
1
$4.84B
2024-05-23
2024-05-28
KANIA EDWIN JR
A - Grant
Common Stock
732
$0.00
1
$4.84B
2024-05-23
2024-05-28
LOVELL STEPHANIE
A - Grant
Stock Option (Right to Buy)
1,154
$0.00
1
$4.84B
2024-05-23
2024-05-28
LOVELL STEPHANIE
A - Grant
Common Stock
732
$0.00
1
$4.84B
2024-05-23
2024-05-28
RAINES MERILEE
A - Grant
Stock Option (Right to Buy)
1,154
$0.00
1
$4.84B
2024-05-23
2024-05-28
RAINES MERILEE
A - Grant
Common Stock
732
$0.00
1
$4.84B
2024-05-23
2024-05-28
TOBIN JAMES
A - Grant
Stock Option (Right to Buy)
1,154
$0.00
1
$4.84B
2024-05-23
2024-05-28
TOBIN JAMES
A - Grant
Common Stock
732
$0.00
1
$4.84B
2024-05-23
2024-05-28
WEILL DAVID
A - Grant
Stock Option (Right to Buy)
1,154
$0.00
1
$4.84B
2024-05-23
2024-05-28
WEILL DAVID
A - Grant
Common Stock
732
$0.00
1
$4.84B
2024-05-15
2024-05-17
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-8,625
$135.00
-1.16M
4
$4.84B
2024-05-15
2024-05-17
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-8,625
$0.00
1
$4.84B
2024-05-15
2024-05-17
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
8,625
$13.00
112K
1
$4.84B
2024-05-10
2024-05-14
WEILL DAVID
S - Sale
Common Stock
-2,500
$130.00
-325K
1
$4.84B
2024-05-01
2024-05-14
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-63,260
$109.00
-6.90M
14
$4.84B
2024-05-07
2024-05-08
BASILE EDWARD
S - Sale
Common Stock
-7,157
$130.00
-930K
5
$4.84B
2024-05-06
2024-05-08
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
30,000
$13.00
390K
1
$4.84B
2024-05-06
2024-05-08
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-5,839
$0.00
1
$4.84B
2024-05-06
2024-05-08
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-15,000
$0.00
1
$4.84B
2024-05-06
2024-05-08
CORCORAN NICHOLAS
SVP of Supply Chain and Operat...
S - Sale
Common Stock
-3,222
$130.00
-419K
1
$4.84B
2024-05-06
2024-05-08
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-15,000
$128.00
-1.92M
1
$4.84B
2024-05-06
2024-05-08
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-30,000
$130.00
-3.90M
1
$4.84B
2024-05-06
2024-05-08
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-5,839
$130.00
-759K
1
$4.84B
2024-05-06
2024-05-08
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
5,839
$66.00
385K
1
$4.84B
2024-05-06
2024-05-08
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
15,000
$38.00
570K
1
$4.84B
2024-05-06
2024-05-08
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-30,000
$0.00
1
$4.84B
2024-05-03
2024-05-07
TOBIN JAMES
S - Sale
Common Stock
-12,025
$125.00
-1.50M
2
$4.84B
2024-05-02
2024-05-03
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-12,444
$121.00
-1.51M
3
$4.84B
2024-05-01
2024-05-03
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-78,036
$110.00
-8.58M
17
$4.84B
2024-05-01
2024-05-03
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-56,000
$0.00
1
$4.84B
2024-05-01
2024-05-03
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
56,000
$13.00
728K
1
$4.84B
2024-05-01
2024-05-03
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-47,867
$0.00
3
$4.84B
2024-05-01
2024-05-03
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
47,867
$38.00
1.82M
3
$4.84B
2024-05-01
2024-05-03
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-56,000
$116.00
-6.50M
6
$4.84B
2024-05-01
2024-05-03
TOBIN JAMES
S - Sale
Common Stock
-15,040
$106.00
-1.59M
4
$4.84B
2024-04-17
2024-04-18
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-4,000
$95.00
-380K
1
$4.84B
2024-04-17
2024-04-18
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-4,000
$0.00
1
$4.84B
2024-04-17
2024-04-18
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
4,000
$13.00
52,000
1
$4.84B
2024-04-10
2024-04-12
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-12,000
$95.00
-1.14M
1
$4.84B
2024-04-10
2024-04-12
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-12,000
$0.00
1
$4.84B
2024-04-10
2024-04-12
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
12,000
$13.00
156K
1
$4.84B
2024-04-10
2024-04-10
HASSANEIN WALEED
President & CEO
S - Sale
-43,250
$90.00
-3.89M
1
$4.84B
2024-04-09
2024-04-10
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-15,512
$0.00
2
$4.84B
2024-04-09
2024-04-10
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-15,512
$90.00
-1.40M
2
$4.84B
2024-04-09
2024-04-10
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
15,512
$26.00
403K
2
$4.84B
2024-04-08
2024-04-10
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
4,388
$16.00
70,208
1
$4.84B
2024-04-08
2024-04-10
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-4,388
$0.00
1
$4.84B
2024-04-08
2024-04-10
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-4,388
$90.00
-395K
1
$4.84B
2024-04-08
2024-04-08
KHAYAL TAMER
Chief Commercial Officer
S - Sale
-19,900
$90.00
-1.79M
1
$4.84B
2024-04-04
2024-04-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-4,947
$0.00
2
$4.84B
2024-04-04
2024-04-05
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-4,947
$80.00
-396K
1
$4.84B
2024-04-04
2024-04-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
4,947
$15.00
74,205
2
$4.84B
2024-04-03
2024-04-05
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-5,053
$80.00
-404K
1
$4.84B
2024-04-03
2024-04-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-5,053
$0.00
1
$4.84B
2024-04-03
2024-04-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
5,053
$13.00
65,689
1
$4.84B
2024-04-03
2024-04-03
KHAYAL TAMER
Chief Commercial Officer
S - Sale
-7,242
$80.00
-579K
1
$4.84B
2024-04-01
2024-04-02
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
15,000
$38.00
570K
1
$4.84B
2024-04-01
2024-04-02
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-15,000
$0.00
1
$4.84B
2024-04-01
2024-04-02
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-15,000
$74.00
-1.11M
1
$4.84B
2024-03-08
2024-03-18
KHAYAL TAMER
Chief Commercial Officer
S - Sale
-1,317
$88.00
-116K
1
$4.84B
2024-03-13
2024-03-13
PROVOST MIRIAM
VP, Global Regulatory Affairs
S - Sale
-1,248
$85.00
-106K
1
$4.84B
2024-03-12
2024-03-12
PROVOST MIRIAM
VP, Global Regulatory Affairs
S - Sale
-1,815
$84.00
-152K
1
$4.84B
2024-03-08
2024-03-12
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-1,903
$88.00
-167K
1
$4.84B
2024-03-08
2024-03-12
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-100
$0.00
1
$4.84B
2024-03-08
2024-03-12
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
100
$16.00
1,600
1
$4.84B
2024-03-08
2024-03-12
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-1,417
$88.00
-125K
2
$4.84B
2024-03-04
2024-03-05
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-15,000
$0.00
1
$4.84B
2024-03-04
2024-03-05
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
15,000
$38.00
570K
1
$4.84B
2024-03-04
2024-03-05
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-15,000
$83.00
-1.25M
1
$4.84B
2024-03-01
2024-03-05
TOBIN JAMES
S - Sale
Common Stock
-13,380
$84.00
-1.12M
5
$4.84B
2024-03-01
2024-03-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$4.84B
2024-03-01
2024-03-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
10,000
$13.00
130K
1
$4.84B
2024-03-01
2024-03-05
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-10,000
$83.00
-830K
5
$4.84B
2023-11-28
2024-03-01
TOBIN JAMES
S - Sale
-13,380
$84.00
-1.12M
1
$4.84B
2024-02-23
2024-02-27
CORCORAN NICHOLAS
SVP of Supply Chain and Operat...
A - Grant
Stock Option (Right to Buy)
17,632
$0.00
1
$4.84B
2024-02-23
2024-02-27
CORCORAN NICHOLAS
SVP of Supply Chain and Operat...
A - Grant
Common Stock
11,441
$0.00
1
$4.84B
2024-02-23
2024-02-27
GORDON STEPHEN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
18,690
$0.00
1
$4.84B
2024-02-23
2024-02-27
GORDON STEPHEN
Chief Financial Officer
A - Grant
Common Stock
12,127
$0.00
1
$4.84B
2024-02-23
2024-02-27
HASSANEIN WALEED
President & CEO
A - Grant
Stock Option (Right to Buy)
56,645
$0.00
1
$4.84B
2024-02-23
2024-02-27
HASSANEIN WALEED
President & CEO
A - Grant
Common Stock
36,755
$0.00
1
$4.84B
2024-02-23
2024-02-27
KHAYAL TAMER
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
18,690
$0.00
1
$4.84B
2024-02-23
2024-02-27
KHAYAL TAMER
Chief Commercial Officer
A - Grant
Common Stock
12,127
$0.00
1
$4.84B
2024-02-20
2024-02-21
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-250
$0.00
1
$4.84B
2024-02-20
2024-02-21
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
250
$16.00
4,000
1
$4.84B
2024-02-20
2024-02-21
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-250
$90.00
-22,500
1
$4.84B
2024-02-16
2024-02-21
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-2,858
$0.00
2
$4.84B
2024-02-16
2024-02-21
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
2,858
$16.00
45,728
2
$4.84B
2024-02-16
2024-02-21
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-2,858
$90.00
-257K
1
$4.84B
2024-02-15
2024-02-16
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-776
$0.00
1
$4.84B
2024-02-15
2024-02-16
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
776
$16.00
12,416
1
$4.84B
2024-02-15
2024-02-16
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-776
$90.00
-69,840
1
$4.84B
2024-02-14
2024-02-16
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-3,050
$0.00
1
$4.84B
2024-02-14
2024-02-16
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-3,050
$90.00
-275K
1
$4.84B
2024-02-14
2024-02-16
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
3,050
$16.00
48,800
1
$4.84B
2024-02-07
2024-02-09
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
736
$16.00
11,776
1
$4.84B
2024-02-07
2024-02-09
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-736
$0.00
1
$4.84B
2024-02-07
2024-02-09
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-736
$90.00
-66,240
1
$4.84B
2024-02-06
2024-02-08
BASILE EDWARD
S - Sale
Common Stock
-7,157
$86.00
-616K
2
$4.84B
2024-02-01
2024-02-02
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
15,000
$18.00
270K
3
$4.84B
2024-02-01
2024-02-02
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-15,000
$0.00
3
$4.84B
2024-02-01
2024-02-02
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-15,000
$85.00
-1.27M
1
$4.84B
2024-01-23
2024-01-25
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-2,330
$0.00
1
$4.84B
2024-01-23
2024-01-25
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
2,330
$16.00
37,280
1
$4.84B
2024-01-23
2024-01-25
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-2,330
$90.00
-210K
1
$4.84B
2024-01-16
2024-01-18
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-10,000
$80.00
-800K
2
$4.84B
2024-01-16
2024-01-18
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$4.84B
2024-01-16
2024-01-18
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
10,000
$13.00
130K
1
$4.84B
2024-01-16
2024-01-16
KHAYAL TAMER
Chief Commercial Officer
S - Sale
-30,000
$81.00
-2.43M
1
$4.84B
2024-01-02
2024-01-03
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-15,000
$0.00
1
$4.84B
2024-01-02
2024-01-03
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
15,000
$13.00
195K
1
$4.84B
2024-01-02
2024-01-03
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-15,000
$77.00
-1.16M
1
$4.84B
2023-12-15
2023-12-15
PROVOST MIRIAM
VP, Global Regulatory Affairs
G - Gift
Common Stock
-1,785
$0.00
1
$4.84B
2023-12-13
2023-12-15
PROVOST MIRIAM
VP, Global Regulatory Affairs
M - Exercise
Stock Option (Right to Buy)
-5,644
$0.00
3
$4.84B
2023-12-13
2023-12-15
PROVOST MIRIAM
VP, Global Regulatory Affairs
M - Exercise
Common Stock
5,644
$45.00
254K
3
$4.84B
2023-12-13
2023-12-15
PROVOST MIRIAM
VP, Global Regulatory Affairs
S - Sale
Common Stock
-4,122
$75.00
-309K
3
$4.84B
2023-12-01
2023-12-05
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,500
$74.00
-555K
3
$4.84B
2023-11-28
2023-11-29
TOBIN JAMES
S - Sale
Common Stock
-10,000
$70.00
-700K
1
$4.84B
2023-11-17
2023-11-21
GORDON STEPHEN
Chief Financial Officer
G - Gift
Common Stock
-5,714
$0.00
1
$4.84B
2023-11-07
2023-11-09
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-15,000
$64.00
-960K
1
$4.84B
2023-11-07
2023-11-07
HASSANEIN WALEED
President & CEO
S - Sale
-22,500
$61.00
-1.37M
1
$4.84B
2023-10-02
2023-10-04
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$4.84B
2023-10-02
2023-10-04
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
5,000
$16.00
80,000
1
$4.84B
2023-10-02
2023-10-04
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-5,000
$54.00
-270K
1
$4.84B
2023-09-01
2023-09-06
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,500
$68.00
-510K
4
$4.84B
2023-08-31
2023-09-05
PROVOST MIRIAM
VP, Global Regulatory Affairs
M - Exercise
Stock Option (Right to Buy)
-5,480
$0.00
2
$4.84B
2023-08-31
2023-09-05
PROVOST MIRIAM
VP, Global Regulatory Affairs
M - Exercise
Common Stock
5,480
$27.00
148K
2
$4.84B
2023-08-31
2023-09-05
PROVOST MIRIAM
VP, Global Regulatory Affairs
S - Sale
Common Stock
-2,708
$67.00
-181K
1
$4.84B
2023-08-29
2023-08-30
WEILL DAVID
P - Purchase
Common Stock
2,500
$62.00
155K
1
$4.84B
2023-08-01
2023-08-04
RANGANATH ANIL
See remarks
A - Grant
Stock Option (Right to Buy)
14,709
$0.00
1
$4.84B
2023-08-01
2023-08-04
RANGANATH ANIL
See remarks
A - Grant
Common Stock
9,512
$0.00
1
$4.84B
2023-08-01
2023-08-03
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,500
$93.00
-698K
3
$4.84B
2023-08-01
2023-08-01
HASSANEIN WALEED
President & CEO
S - Sale
-22,500
$94.00
-2.12M
1
$4.84B
2023-07-18
2023-07-19
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
2
$4.84B
2023-07-18
2023-07-19
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
5,000
$23.00
115K
2
$4.84B
2023-07-18
2023-07-19
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-5,000
$95.00
-475K
1
$4.84B
2023-07-13
2023-07-17
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-2,974
$0.00
1
$4.84B
2023-07-13
2023-07-17
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
2,974
$16.00
47,584
1
$4.84B
2023-07-13
2023-07-17
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-5,199
$90.00
-468K
2
$4.84B
2023-07-13
2023-07-13
KHAYAL TAMER
Chief Commercial Officer
S - Sale
-7,974
$90.00
-718K
1
$4.84B
2023-07-13
2023-07-13
KHAYAL TAMER
Chief Commercial Officer
S - Sale
-10,199
$90.00
-918K
2
$4.84B
2023-07-03
2023-07-06
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,500
$83.00
-623K
3
$4.84B
2023-06-01
2023-06-05
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,500
$72.00
-540K
2
$4.84B
2023-05-25
2023-05-30
WEILL DAVID
A - Grant
Stock Option (Right to Buy)
1,916
$0.00
1
$4.84B
2023-05-25
2023-05-30
WEILL DAVID
A - Grant
Common Stock
1,193
$0.00
1
$4.84B
2023-05-25
2023-05-30
BASILE EDWARD
A - Grant
Stock Option (Right to Buy)
1,916
$0.00
1
$4.84B
2023-05-25
2023-05-30
GUNDERSON THOMAS JAMES
A - Grant
Stock Option (Right to Buy)
1,916
$0.00
1
$4.84B
2023-05-25
2023-05-30
GUNDERSON THOMAS JAMES
A - Grant
Common Stock
1,193
$0.00
1
$4.84B
2023-05-25
2023-05-30
KANIA EDWIN JR
A - Grant
Stock Option (Right to Buy)
1,916
$0.00
1
$4.84B
2023-05-25
2023-05-30
KANIA EDWIN JR
A - Grant
Common Stock
1,193
$0.00
1
$4.84B
2023-05-25
2023-05-30
LOVELL STEPHANIE
A - Grant
Stock Option (Right to Buy)
1,916
$0.00
1
$4.84B
2023-05-25
2023-05-30
LOVELL STEPHANIE
A - Grant
Common Stock
1,193
$0.00
1
$4.84B
2023-05-25
2023-05-30
RAINES MERILEE
A - Grant
Common Stock
1,193
$0.00
1
$4.84B
2023-05-25
2023-05-30
RAINES MERILEE
A - Grant
Stock Option (Right to Buy)
1,916
$0.00
1
$4.84B
2023-05-25
2023-05-30
BASILE EDWARD
A - Grant
Common Stock
1,193
$0.00
1
$4.84B
2023-05-25
2023-05-30
TOBIN JAMES
A - Grant
Stock Option (Right to Buy)
1,916
$0.00
1
$4.84B
2023-05-25
2023-05-30
TOBIN JAMES
A - Grant
Common Stock
1,193
$0.00
1
$4.84B
2023-05-01
2023-05-02
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$4.84B
2023-05-01
2023-05-02
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
5,000
$16.00
80,000
1
$4.84B
2023-05-01
2023-05-02
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-5,000
$79.00
-395K
1
$4.84B
2023-05-01
2023-05-02
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,500
$78.00
-585K
3
$4.84B
2023-05-01
2023-05-01
CAREY JOHN
VP of Operations
S - Sale
-2,821
$79.00
-223K
1
$4.84B
2023-05-01
2023-05-01
HASSANEIN WALEED
President & CEO
S - Sale
-22,500
$79.00
-1.78M
1
$4.84B
2023-04-21
2023-04-25
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
12,026
$16.00
192K
2
$4.84B
2023-04-21
2023-04-25
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-14,801
$87.00
-1.29M
4
$4.84B
2023-04-21
2023-04-25
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-12,026
$0.00
2
$4.84B
2023-04-21
2023-04-21
KHAYAL TAMER
Chief Commercial Officer
S - Sale
-5,000
$81.00
-405K
1
$4.84B
2023-04-21
2023-04-21
KHAYAL TAMER
Chief Commercial Officer
S - Sale
-5,000
$81.00
-405K
1
$4.84B
2023-04-03
2023-04-04
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,500
$75.00
-563K
3
$4.84B
2023-03-10
2023-03-14
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-193K
$0.00
1
$4.84B
2023-03-10
2023-03-14
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
193K
$2.00
386K
1
$4.84B
2023-03-01
2023-03-02
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$4.84B
2023-03-01
2023-03-02
BASILE EDWARD
S - Sale
Common Stock
-3,500
$80.00
-280K
1
$4.84B
2023-03-01
2023-03-02
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-5,000
$80.00
-400K
1
$4.84B
2023-03-01
2023-03-02
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,500
$81.00
-608K
2
$4.84B
2023-03-01
2023-03-02
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
5,000
$16.00
80,000
1
$4.84B
2023-02-28
2023-03-02
KANIA EDWIN JR
J - Other
Common Stock
242K
$80.00
19M
2
$4.84B
2023-02-28
2023-03-02
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-15,000
$80.00
-1.20M
2
$4.84B
2023-02-28
2023-03-02
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$4.84B
2023-02-28
2023-03-02
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
10,000
$16.00
160K
1
$4.84B
2023-02-27
2023-02-28
BASILE EDWARD
S - Sale
Common Stock
-5,000
$78.00
-390K
3
$4.84B
2023-02-27
2023-02-28
WEILL DAVID
S - Sale
Common Stock
-5,934
$77.00
-457K
2
$4.84B
2023-02-27
2023-02-28
WEILL DAVID
M - Exercise
Stock Option (Right to Buy)
-5,934
$0.00
1
$4.84B
2023-02-27
2023-02-28
WEILL DAVID
M - Exercise
Common Stock
5,934
$14.00
83,076
1
$4.84B
2023-02-23
2023-02-27
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-37,827
$74.00
-2.80M
5
$4.84B
2023-02-23
2023-02-27
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-35,930
$74.00
-2.66M
6
$4.84B
2023-02-23
2023-02-27
TOBIN JAMES
S - Sale
Common Stock
-10,000
$75.00
-750K
1
$4.84B
2023-02-23
2023-02-27
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-35,930
$0.00
2
$4.84B
2023-02-23
2023-02-27
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
35,930
$16.00
575K
2
$4.84B
2023-02-20
2023-02-22
KHAYAL TAMER
Chief Commercial Officer
A - Grant
Common Stock
13,075
$0.00
1
$4.84B
2023-02-20
2023-02-22
PROVOST MIRIAM
VP, Global Regulatory Affairs
A - Grant
Stock Option (Right to Buy)
8,705
$0.00
1
$4.84B
2023-02-20
2023-02-22
PROVOST MIRIAM
VP, Global Regulatory Affairs
A - Grant
Common Stock
5,685
$0.00
1
$4.84B
2023-02-20
2023-02-22
CORCORAN NICHOLAS
SVP of Supply Chain and Operat...
A - Grant
Stock Option (Right to Buy)
19,732
$0.00
1
$4.84B
2023-02-20
2023-02-22
CORCORAN NICHOLAS
SVP of Supply Chain and Operat...
A - Grant
Common Stock
12,886
$0.00
1
$4.84B
2023-02-20
2023-02-22
DAMME LAURA
VP, Clinical Affairs
A - Grant
Stock Option (Right to Buy)
8,705
$0.00
1
$4.84B
2023-02-20
2023-02-22
DAMME LAURA
VP, Clinical Affairs
A - Grant
Common Stock
5,685
$0.00
1
$4.84B
2023-02-20
2023-02-22
GORDON STEPHEN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
20,022
$0.00
1
$4.84B
2023-02-20
2023-02-22
GORDON STEPHEN
Chief Financial Officer
A - Grant
Common Stock
13,075
$0.00
1
$4.84B
2023-02-20
2023-02-22
HASSANEIN WALEED
President & CEO
A - Grant
Stock Option (Right to Buy)
57,165
$0.00
1
$4.84B
2023-02-20
2023-02-22
HASSANEIN WALEED
President & CEO
A - Grant
Common Stock
37,332
$0.00
1
$4.84B
2023-02-20
2023-02-22
KHAYAL TAMER
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
20,022
$0.00
1
$4.84B
2023-02-14
2023-02-16
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-2,173
$70.00
-152K
1
$4.84B
2023-02-14
2023-02-16
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-4,070
$70.00
-285K
1
$4.84B
2023-02-14
2023-02-16
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-4,070
$0.00
1
$4.84B
2023-02-14
2023-02-16
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
4,070
$16.00
65,120
1
$4.84B
2023-02-01
2023-02-03
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
5,000
$16.00
80,000
1
$4.84B
2023-02-01
2023-02-03
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-1,410
$63.00
-88,830
5
$4.84B
2023-02-01
2023-02-03
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-5,000
$63.00
-315K
1
$4.84B
2023-02-01
2023-02-03
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,500
$64.00
-480K
1
$4.84B
2023-02-01
2023-02-03
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-1,410
$0.00
2
$4.84B
2023-02-01
2023-02-03
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
1,410
$17.00
23,970
2
$4.84B
2023-02-01
2023-02-03
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$4.84B
2023-01-23
2023-01-25
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-3,142
$0.00
1
$4.84B
2023-01-23
2023-01-25
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
3,142
$16.00
50,272
1
$4.84B
2023-01-23
2023-01-25
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-12,362
$65.00
-804K
2
$4.84B
2023-01-23
2023-01-25
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-3,142
$65.00
-204K
1
$4.84B
2023-01-20
2023-01-20
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
5,558
$16.00
88,928
1
$4.84B
2023-01-20
2023-01-20
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-6,332
$65.00
-412K
1
$4.84B
2023-01-20
2023-01-20
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-5,558
$65.00
-361K
1
$4.84B
2023-01-20
2023-01-20
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-5,558
$0.00
1
$4.84B
2023-01-18
2023-01-20
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-1,300
$0.00
1
$4.84B
2023-01-18
2023-01-20
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-1,306
$65.00
-84,890
1
$4.84B
2023-01-18
2023-01-20
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-1,300
$65.00
-84,500
1
$4.84B
2023-01-18
2023-01-20
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
1,300
$16.00
20,800
1
$4.84B
2023-01-17
2023-01-18
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-5,000
$60.00
-300K
1
$4.84B
2023-01-17
2023-01-18
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,500
$64.00
-480K
1
$4.84B
2023-01-17
2023-01-18
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-1,410
$0.00
1
$4.84B
2023-01-17
2023-01-18
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
1,410
$38.00
53,580
1
$4.84B
2023-01-17
2023-01-18
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$4.84B
2023-01-17
2023-01-18
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
5,000
$16.00
80,000
1
$4.84B
2023-01-17
2023-01-18
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-1,410
$63.00
-88,830
5
$4.84B
2023-01-13
2023-01-17
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-5,900
$60.00
-354K
1
$4.84B
2023-01-13
2023-01-17
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-5,900
$0.00
1
$4.84B
2023-01-13
2023-01-17
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
5,900
$16.00
94,400
1
$4.84B
2023-01-03
2023-01-05
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-4,100
$62.00
-254K
3
$4.84B
2023-01-03
2023-01-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-4,100
$0.00
1
$4.84B
2023-01-03
2023-01-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
4,100
$16.00
65,600
1
$4.84B
2022-12-15
2022-12-16
DAMME LAURA
VP, Clinical Affairs
M - Exercise
Common Stock
4,990
$38.00
190K
2
$4.84B
2022-12-15
2022-12-16
DAMME LAURA
VP, Clinical Affairs
S - Sale
Common Stock
-4,990
$59.00
-294K
2
$4.84B
2022-12-15
2022-12-16
DAMME LAURA
VP, Clinical Affairs
M - Exercise
Stock Option (Right to Buy)
-4,990
$0.00
2
$4.84B
2022-12-14
2022-12-16
DAMME LAURA
VP, Clinical Affairs
M - Exercise
Common Stock
5,947
$38.00
226K
1
$4.84B
2022-12-14
2022-12-16
DAMME LAURA
VP, Clinical Affairs
S - Sale
Common Stock
-5,947
$62.00
-369K
1
$4.84B
2022-12-14
2022-12-16
DAMME LAURA
VP, Clinical Affairs
M - Exercise
Stock Option (Right to Buy)
-5,947
$0.00
1
$4.84B
2022-12-13
2022-12-15
PROVOST MIRIAM
VP, Global Regulatory Affairs
S - Sale
Common Stock
-4,315
$63.00
-272K
2
$4.84B
2022-12-13
2022-12-15
PROVOST MIRIAM
VP, Global Regulatory Affairs
M - Exercise
Stock Option (Right to Buy)
-5,918
$0.00
1
$4.84B
2022-12-13
2022-12-15
PROVOST MIRIAM
VP, Global Regulatory Affairs
M - Exercise
Common Stock
5,918
$38.00
225K
1
$4.84B
2022-12-09
2022-12-13
PROVOST MIRIAM
VP, Global Regulatory Affairs
S - Sale
Common Stock
-3,613
$59.00
-213K
2
$4.84B
2022-12-09
2022-12-13
PROVOST MIRIAM
VP, Global Regulatory Affairs
M - Exercise
Stock Option (Right to Buy)
-5,126
$0.00
2
$4.84B
2022-12-09
2022-12-13
PROVOST MIRIAM
VP, Global Regulatory Affairs
M - Exercise
Common Stock
5,126
$33.00
169K
2
$4.84B
2022-09-02
2022-12-13
PROVOST MIRIAM
VP, Global Regulatory Affairs
M - Exercise
Stock Option (Right to Buy)
-2,600
$0.00
1
$4.84B
2022-09-02
2022-12-13
PROVOST MIRIAM
VP, Global Regulatory Affairs
M - Exercise
Common Stock
2,600
$3.00
7,800
1
$4.84B
2022-12-05
2022-12-05
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-36
$0.00
1
$4.84B
2022-12-05
2022-12-05
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
36
$0.00
1
$4.84B
2022-12-02
2022-12-05
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
23,037
$17.00
392K
3
$4.84B
2022-12-02
2022-12-05
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-10,000
$64.00
-640K
1
$4.84B
2022-12-02
2022-12-05
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-23,037
$0.00
3
$4.84B
2022-12-01
2022-12-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
11,051
$2.00
22,102
1
$4.84B
2022-12-01
2022-12-05
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-3,000
$61.00
-183K
3
$4.84B
2022-12-01
2022-12-05
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-10,000
$61.00
-610K
2
$4.84B
2022-12-01
2022-12-05
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$4.84B
2022-12-01
2022-12-05
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
3,000
$0.00
1
$4.84B
2022-12-01
2022-12-05
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$4.84B
2022-12-01
2022-12-05
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
10,000
$16.00
160K
1
$4.84B
2022-12-01
2022-12-05
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-11,051
$0.00
1
$4.84B
2022-11-23
2022-11-23
LOVELL STEPHANIE
S - Sale
Common Stock
-5,657
$60.00
-339K
1
$4.84B
2022-11-23
2022-11-23
LOVELL STEPHANIE
M - Exercise
Stock Option (Right to Buy)
-5,657
$0.00
1
$4.84B
2022-11-23
2022-11-23
LOVELL STEPHANIE
M - Exercise
Common Stock
5,657
$48.00
272K
1
$4.84B
2022-11-22
2022-11-23
LOVELL STEPHANIE
M - Exercise
Stock Option (Right to Buy)
-4,900
$0.00
2
$4.84B
2022-11-22
2022-11-23
LOVELL STEPHANIE
S - Sale
Common Stock
-4,900
$58.00
-284K
2
$4.84B
2022-11-22
2022-11-23
LOVELL STEPHANIE
M - Exercise
Common Stock
4,900
$43.00
211K
2
$4.84B
2022-11-15
2022-11-16
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-4,254
$0.00
1
$4.84B
2022-11-15
2022-11-16
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-14,483
$60.00
-869K
1
$4.84B
2022-11-15
2022-11-16
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-4,254
$60.00
-255K
1
$4.84B
2022-11-15
2022-11-16
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
4,254
$2.00
8,508
1
$4.84B
2022-11-11
2022-11-14
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-2,702
$60.00
-162K
1
$4.84B
2022-11-11
2022-11-14
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-2,702
$0.00
1
$4.84B
2022-11-11
2022-11-14
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
2,702
$2.00
5,404
1
$4.84B
2022-11-11
2022-11-14
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-2,748
$60.00
-165K
1
$4.84B
2022-11-10
2022-11-14
WEILL DAVID
M - Exercise
Stock Option (Right to Buy)
-21,645
$0.00
1
$4.84B
2022-11-10
2022-11-14
WEILL DAVID
S - Sale
Common Stock
-21,645
$56.00
-1.21M
1
$4.84B
2022-11-10
2022-11-14
WEILL DAVID
M - Exercise
Common Stock
21,645
$16.00
346K
1
$4.84B
2022-11-07
2022-11-09
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-10,000
$57.00
-570K
1
$4.84B
2022-11-07
2022-11-09
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-2,769
$60.00
-166K
1
$4.84B
2022-11-07
2022-11-09
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-3,044
$60.00
-183K
1
$4.84B
2022-11-07
2022-11-09
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
2
$4.84B
2022-11-07
2022-11-09
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
10,000
$15.00
150K
2
$4.84B
2022-11-07
2022-11-09
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-3,044
$0.00
1
$4.84B
2022-11-07
2022-11-09
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
3,044
$2.00
6,088
1
$4.84B
2022-11-01
2022-11-03
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$4.84B
2022-11-01
2022-11-03
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
3,000
$0.00
1
$4.84B
2022-11-01
2022-11-03
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-3,000
$49.00
-147K
2
$4.84B
2022-10-03
2022-10-04
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
3,000
$1.00
3,000
2
$4.84B
2022-10-03
2022-10-04
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$4.84B
2022-10-03
2022-10-04
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
10,000
$2.00
20,000
1
$4.84B
2022-10-03
2022-10-04
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
2
$4.84B
2022-10-03
2022-10-04
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-3,000
$42.00
-126K
2
$4.84B
2022-10-03
2022-10-04
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-10,000
$42.00
-420K
1
$4.84B
2022-09-08
2022-09-09
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-17,723
$55.00
-975K
1
$4.84B
2022-09-07
2022-09-09
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-2,277
$55.00
-125K
1
$4.84B
2022-09-01
2022-09-02
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$4.84B
2022-09-01
2022-09-02
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-3,000
$51.00
-153K
2
$4.84B
2022-09-01
2022-09-02
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-10,000
$51.00
-510K
1
$4.84B
2022-09-01
2022-09-02
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$4.84B
2022-09-01
2022-09-02
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
3,000
$2.00
6,000
1
$4.84B
2022-09-01
2022-09-02
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
10,000
$2.00
20,000
1
$4.84B
2022-08-24
2022-08-25
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
1,976
$2.00
3,952
1
$4.84B
2022-08-24
2022-08-25
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-1,976
$0.00
1
$4.84B
2022-08-24
2022-08-25
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-3,591
$50.00
-180K
1
$4.84B
2022-08-24
2022-08-25
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-4,490
$50.00
-225K
2
$4.84B
2022-08-23
2022-08-25
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
8,024
$2.00
16,048
1
$4.84B
2022-08-23
2022-08-25
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-8,024
$0.00
1
$4.84B
2022-08-23
2022-08-25
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-16,409
$50.00
-820K
1
$4.84B
2022-08-23
2022-08-25
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-15,510
$50.00
-776K
2
$4.84B
2022-08-12
2022-08-15
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-7,000
$48.00
-336K
1
$4.84B
2022-08-11
2022-08-15
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-12,929
$47.00
-608K
1
$4.84B
2022-08-08
2022-08-09
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-10,000
$48.00
-480K
1
$4.84B
2022-08-08
2022-08-09
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$4.84B
2022-08-08
2022-08-09
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
10,000
$2.00
20,000
1
$4.84B
2022-08-05
2022-08-09
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$4.84B
2022-08-05
2022-08-09
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-20,000
$45.00
-900K
2
$4.84B
2022-08-05
2022-08-09
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
10,000
$2.00
20,000
1
$4.84B
2022-08-05
2022-08-09
HASSANEIN WALEED
President & CEO
S - Sale
Common Stock
-20,000
$45.00
-900K
1
$4.84B
2022-08-01
2022-08-01
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-3,000
$41.00
-123K
3
$4.84B
2022-08-01
2022-08-01
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-3,000
$0.00
1
$4.84B
2022-08-01
2022-08-01
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
3,000
$2.00
6,000
1
$4.84B
2022-07-29
2022-08-01
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-4,000
$40.00
-160K
1
$4.84B
2022-07-29
2022-08-01
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-4,000
$0.00
2
$4.84B
2022-07-29
2022-08-01
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
4,000
$8.00
32,000
2
$4.84B
2022-07-29
2022-08-01
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-13,504
$0.00
2
$4.84B
2022-07-29
2022-08-01
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
13,504
$1.00
13,504
2
$4.84B
2022-07-29
2022-08-01
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-13,504
$40.00
-540K
1
$4.84B
2022-07-29
2022-08-01
TOBIN JAMES
S - Sale
Common Stock
-48,515
$40.00
-1.94M
1
$4.84B
2022-07-20
2022-07-22
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-1,500
$35.00
-52,500
1
$4.84B
2022-07-20
2022-07-22
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-1,500
$0.00
2
$4.84B
2022-07-20
2022-07-22
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
1,500
$14.00
21,000
2
$4.84B
2022-07-11
2022-07-12
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-1,500
$33.00
-49,500
1
$4.84B
2022-07-11
2022-07-12
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-1,500
$0.00
1
$4.84B
2022-07-11
2022-07-12
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
1,500
$16.00
24,000
1
$4.84B
2022-07-05
2022-07-06
GORDON STEPHEN
Chief Financial Officer
S - Sale
Common Stock
-10,000
$35.00
-350K
1
$4.84B
2022-07-05
2022-07-06
KHAYAL TAMER
Chief Commercial Officer
S - Sale
Common Stock
-13,504
$35.00
-473K
1
$4.84B
2022-07-05
2022-07-06
TOBIN JAMES
S - Sale
Common Stock
-48,515
$35.00
-1.70M
1
$4.84B
2022-07-05
2022-07-06
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$4.84B
2022-07-05
2022-07-06
GORDON STEPHEN
Chief Financial Officer
M - Exercise
Common Stock
10,000
$2.00
20,000
1
$4.84B
2022-07-05
2022-07-06
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-13,504
$0.00
1
$4.84B
2022-07-05
2022-07-06
KHAYAL TAMER
Chief Commercial Officer
M - Exercise
Common Stock
13,504
$0.00
1
$4.84B
2022-06-28
2022-06-29
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-2,724
$0.00
1
$4.84B
2022-06-28
2022-06-29
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-2,724
$33.00
-89,892
1
$4.84B
2022-06-28
2022-06-29
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
2,724
$0.00
1
$4.84B
2022-06-27
2022-06-27
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
3,320
$0.00
1
$4.84B
2022-06-27
2022-06-27
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-3,320
$0.00
1
$4.84B
2022-06-27
2022-06-27
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
3,320
$0.00
1
$4.84B
2022-06-27
2022-06-27
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-3,320
$33.00
-110K
1
$4.84B
2022-06-27
2022-06-27
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-3,320
$33.00
-110K
1
$4.84B
2022-06-27
2022-06-27
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-3,320
$0.00
1
$4.84B
2022-06-24
2022-06-27
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-2,956
$33.00
-97,548
1
$4.84B
2022-06-24
2022-06-27
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-2,956
$0.00
1
$4.84B
2022-06-24
2022-06-27
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
2,956
$0.00
1
$4.84B
2022-06-01
2022-06-06
BASILE EDWARD
A - Grant
Stock Option (Right to Buy)
13,500
$0.00
1
$4.84B
2022-06-01
2022-06-06
GUNDERSON THOMAS JAMES
A - Grant
Stock Option (Right to Buy)
13,500
$0.00
1
$4.84B
2022-06-01
2022-06-06
KANIA EDWIN JR
A - Grant
Stock Option (Right to Buy)
13,500
$0.00
1
$4.84B
2022-06-01
2022-06-06
LOVELL STEPHANIE
A - Grant
Stock Option (Right to Buy)
13,500
$0.00
1
$4.84B
2022-06-01
2022-06-06
RAINES MERILEE
A - Grant
Stock Option (Right to Buy)
13,500
$0.00
1
$4.84B
2022-06-01
2022-06-06
TOBIN JAMES
A - Grant
Stock Option (Right to Buy)
13,500
$0.00
1
$4.84B
2022-06-01
2022-06-06
WEILL DAVID
A - Grant
Stock Option (Right to Buy)
13,500
$0.00
1
$4.84B
2022-06-01
2022-06-03
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
1,500
$0.00
1
$4.84B
2022-06-01
2022-06-03
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-1,500
$28.00
-42,000
2
$4.84B
2022-06-01
2022-06-03
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-1,500
$0.00
1
$4.84B
2022-05-04
2022-05-06
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-1,500
$0.00
1
$4.84B
2022-05-04
2022-05-06
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
1,500
$0.00
1
$4.84B
2022-05-04
2022-05-06
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-1,500
$25.00
-37,500
1
$4.84B
2022-05-04
2022-05-06
TOBIN JAMES
S - Sale
Common Stock
-48,516
$30.00
-1.46M
1
$4.84B
2022-04-01
2022-04-04
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-1,500
$27.00
-40,500
1
$4.84B
2022-04-01
2022-04-04
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-1,500
$0.00
1
$4.84B
2022-04-01
2022-04-04
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
1,500
$0.00
1
$4.84B
2022-03-28
2022-03-30
CAREY JOHN
VP of Operations
S - Sale
Common Stock
-4,500
$25.00
-113K
1
$4.84B
2022-03-28
2022-03-30
CAREY JOHN
VP of Operations
M - Exercise
Stock Option (Right to Buy)
-4,500
$0.00
3
$4.84B
2022-03-28
2022-03-30
CAREY JOHN
VP of Operations
M - Exercise
Common Stock
4,500
$11.00
49,500
3
$4.84B
2022-02-22
2022-02-24
CAREY JOHN
VP of Operations
A - Grant
Stock Option (Right to Buy)
38,000
$0.00
1
$4.84B
2022-02-22
2022-02-24
DAMME LAURA
VP, Clinical Affairs
A - Grant
Stock Option (Right to Buy)
38,000
$0.00
1
$4.84B
2022-02-22
2022-02-24
GORDON STEPHEN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
52,000
$0.00
1
$4.84B
2022-02-22
2022-02-24
HASSANEIN WALEED
President & CEO
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$4.84B
2022-02-22
2022-02-24
KHAYAL TAMER
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
52,000
$0.00
1
$4.84B
2022-02-22
2022-02-24
PROVOST MIRIAM
VP of Global Regl. Affairs
A - Grant
Stock Option (Right to Buy)
38,000
$0.00
1
$4.84B
2022-01-06
2022-01-07
HASSANEIN WALEED
President & CEO
M - Exercise
Stock Option (Right to Buy)
-122K
$0.00
1
$4.84B
2022-01-06
2022-01-07
HASSANEIN WALEED
President & CEO
M - Exercise
Common Stock
122K
$0.00
1
$4.84B
2021-12-23
2021-12-28
PROVOST MIRIAM
VP of US Regulatory & FDA Rel.
M - Exercise
Stock Option (Right to Buy)
-884
$0.00
1
$4.84B
2021-12-23
2021-12-28
PROVOST MIRIAM
VP of US Regulatory & FDA Rel.
M - Exercise
Common Stock
884
$3.00
2,652
1
$4.84B
2021-12-15
2021-12-16
TOBIN JAMES
G - Gift
Common Stock
-25,500
$0.00
1
$4.84B
2021-11-29
2021-11-30
KANIA EDWIN JR
P - Purchase
Common Stock
100K
$23.00
2.30M
2
$4.84B
2021-11-19
2021-11-22
KANIA EDWIN JR
J - Other
Common Stock
48,966
$0.00
1
$4.84B
2021-11-19
2021-11-22
KANIA EDWIN JR
J - Other
Common Stock
-3,873
$0.00
1
$4.84B
2021-11-17
2021-11-22
KANIA EDWIN JR
J - Other
Common Stock
-851K
$0.00
3
$4.84B